Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical Shareholders Equity (Quarterly) : 1.847B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.847B |
| March 31, 2026 | 1.867B |
| December 31, 2025 | 1.808B |
| September 30, 2025 | 1.860B |
| June 30, 2025 | 1.947B |
| March 31, 2025 | 1.914B |
| December 31, 2024 | 1.807B |
| September 30, 2024 | 2.020B |
| June 30, 2024 | 1.907B |
| March 31, 2024 | 2.022B |
| December 31, 2023 | 2.119B |
| September 30, 2023 | 2.059B |
| June 30, 2023 | 2.082B |
| March 31, 2023 | 2.209B |
| December 31, 2022 | 2.281B |
| September 30, 2022 | 2.142B |
| June 30, 2022 | 2.529B |
| March 31, 2022 | 2.781B |
| December 31, 2021 | 2.791B |
| September 30, 2021 | 2.865B |
| June 30, 2021 | 2.807B |
| March 31, 2021 | 2.807B |
| December 31, 2020 | 3.053B |
| September 30, 2020 | 2.995B |
| June 30, 2020 | 2.838B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.805B |
| December 31, 2019 | 2.781B |
| September 30, 2019 | 2.717B |
| June 30, 2019 | 2.676B |
| March 31, 2019 | 2.628B |
| December 31, 2018 | 2.708B |
| September 30, 2018 | 2.667B |
| June 30, 2018 | 2.596B |
| March 31, 2018 | 2.688B |
| December 31, 2017 | 2.481B |
| September 30, 2017 | 2.399B |
| June 30, 2017 | 2.312B |
| March 31, 2017 | 2.289B |
| December 31, 2016 | 2.170B |
| September 30, 2016 | 2.519B |
| June 30, 2016 | 2.498B |
| March 31, 2016 | 2.313B |
| December 31, 2015 | 2.150B |
| September 30, 2015 | 2.095B |
| June 30, 2015 | 1.769B |
| March 31, 2015 | 1.707B |
| December 31, 2014 | 1.631B |
| September 30, 2014 | 1.716B |
| June 30, 2014 | 1.784B |
| March 31, 2014 | 1.760B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 46.50B |
| Daiichi Sankyo Co., Ltd. | 10.48B |
| Eisai Co., Ltd. | 5.578B |
| Chugai Pharmaceutical Co., Ltd. | 12.48B |
| Ono Pharmaceutical Co., Ltd. | 5.334B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.559B |
| Total Liabilities (Quarterly) | 717.30M |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 2.816 |
| Net Debt Paydown Yield | 0.18% |